Project R-12677

Title

Evaluation of commercialization roadmaps for a new target in MS (Research)

Abstract

For a new therapeutic target for multiple sclerosis, the market potential and most optimal development route for successful commercialisation will be analysed. This will support downstream strategic decisions for the valorisation roadmap.

Period of project

01 March 2022 - 28 February 2023

Information for

Programmes

Hasselt University

Tools